Literature DB >> 9514263

Prime region subsite specificity characterization of human cathepsin D: the dominant role of position 128.

B M Beyer1, B M Dunn.   

Abstract

In order to contribute to our understanding of cathepsin D (CatD) active site specificity, two series of chromogenic octapeptides with systematic substitutions in positions P2' and P3' were synthesized. This panel was characterized with native human liver cathepsin D (nHuCatD) and yielded information concerning specificity trends within the S2' and S3' subsites. The pepstatin inhibited crystal structure of nHuCatD (Baldwin et al., 1993) was then utilized in conjunction with these subsite preference data to identify residues suspected of contributing to "prime" side subsite specificity. These residues were targeted for site-directed mutagenesis using the re-engineered recombinant model, "short" pseudocathepsin D (Beyer & Dunn, 1996). As a result of these analyses it was determined that prime region subsites do contribute to the unique specificity of human CatD. Furthermore, it was ascertained that the poly-proline loop does not have an active role in S3' subsite specificity. Lastly, it appears that Ile128 has a dominant role on S2' subsite specificity whereas Val130 does not.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514263      PMCID: PMC2143827          DOI: 10.1002/pro.5560070109

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  14 in total

1.  Cathepsin D is membrane-associated in macrophage endosomes.

Authors:  S Diment; M S Leech; P D Stahl
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

2.  Production of biologically active fragments of parathyroid hormone by isolated Kupffer cells.

Authors:  S Pillai; J E Zull
Journal:  J Biol Chem       Date:  1986-11-15       Impact factor: 5.157

3.  Processing of the beta-amyloid precursor. Multiple proteases generate and degrade potentially amyloidogenic fragments.

Authors:  R Siman; S Mistretta; J T Durkin; M J Savage; T Loh; S Trusko; R W Scott
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

4.  Redesign of the substrate specificity of human cathepsin D: the dominant role of position 287 in the S2 subsite.

Authors:  P E Scarborough; B M Dunn
Journal:  Protein Eng       Date:  1994-04

5.  Self-activation of recombinant human lysosomal procathepsin D at a newly engineered cleavage junction, "short" pseudocathepsin D.

Authors:  B M Beyer; B M Dunn
Journal:  J Biol Chem       Date:  1996-06-28       Impact factor: 5.157

6.  X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen.

Authors:  C G Dealwis; C Frazao; M Badasso; J B Cooper; I J Tickle; H Driessen; T L Blundell; K Murakami; H Miyazaki; J Sueiras-Diaz
Journal:  J Mol Biol       Date:  1994-02-11       Impact factor: 5.469

7.  Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.

Authors:  E T Baldwin; T N Bhat; S Gulnik; M V Hosur; R C Sowder; R E Cachau; J Collins; A M Silva; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

8.  Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling.

Authors:  P E Scarborough; K Guruprasad; C Topham; G R Richo; G E Conner; T L Blundell; B M Dunn
Journal:  Protein Sci       Date:  1993-02       Impact factor: 6.725

9.  Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D.

Authors:  G E Conner; G Richo
Journal:  Biochemistry       Date:  1992-02-04       Impact factor: 3.162

10.  Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation.

Authors:  C M Rao; P E Scarborough; J Kay; B Batley; S Rapundalo; S Klutchko; M D Taylor; E A Lunney; C C Humblet; B M Dunn
Journal:  J Med Chem       Date:  1993-09-03       Impact factor: 7.446

View more
  4 in total

1.  Active site specificity of plasmepsin II.

Authors:  J Westling; P Cipullo; S H Hung; H Saft; J B Dame; B M Dunn
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

2.  Alpha1-antichymotrypsin and kallistatin hydrolysis by human cathepsin D.

Authors:  D C Pimenta; V C Chen; J Chao; M A Juliano; L Juliano
Journal:  J Protein Chem       Date:  2000-07

3.  Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis.

Authors:  Peng Liu; Melissa R Marzahn; Arthur H Robbins; Hugo Gutiérrez-de-Terán; David Rodríguez; Scott H McClung; Stanley M Stevens; Charles A Yowell; John B Dame; Robert McKenna; Ben M Dunn
Journal:  Biochemistry       Date:  2009-05-19       Impact factor: 3.162

4.  Multiplicity of aspartic proteinases from Cynara cardunculus L.

Authors:  Ana Cristina Sarmento; Henrique Lopes; Cláudia S Oliveira; Rui Vitorino; Bart Samyn; Kjell Sergeant; Griet Debyser; Jozef Van Beeumen; Pedro Domingues; Francisco Amado; Euclides Pires; M Rosário M Domingues; Marlene T Barros
Journal:  Planta       Date:  2009-06-02       Impact factor: 4.116

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.